Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital

Antimicrobial Agents and Chemotherapy
Mei DengLan-Juan Li

Abstract

Because of its remarkable ability to acquire antibiotic resistance and to survive in nosocomial environments, Acinetobacter baumannii has become a significant nosocomial infectious agent worldwide. Tigecycline is one of the few therapeutic options for treating infections caused by A. baumannii isolates. However, tigecycline resistance has increasingly been reported. Our aim was to assess the prevalence and characteristics of efflux-based tigecycline resistance in clinical isolates of A. baumannii collected from a hospital in China. A total of 74 A. baumannii isolates, including 64 tigecycline-nonsusceptible A. baumannii (TNAB) and 10 tigecycline-susceptible A. baumannii (TSAB) isolates, were analyzed. The majority of them were determined to be positive for adeABC, adeRS, adeIJK, and abeM, while the adeE gene was found in only one TSAB isolate. Compared with the levels in TSAB isolates, the mean expression levels of adeB, adeJ, adeG, and abeM in TNAB isolates were observed to increase 29-, 3-, 0.7-, and 1-fold, respectively. The efflux pump inhibitors (EPIs) phenyl-arginine-β-naphthylamide (PAβN) and carbonyl cyanide 3-chlorophenylhydrazone (CCCP) could partially reverse the resistance pattern of tigecycline. Moreover, the tetX1...Continue Reading

References

Sep 1, 2005·Biochemistry·Ian F MooreGerard D Wright
Sep 8, 2005·Journal of Clinical Microbiology·Sergio G BartualFrancisco Rodríguez-Valera
Oct 27, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Nov 4, 2006·The Journal of Antimicrobial Chemotherapy·Anton Y PelegDavid L Paterson
Apr 11, 2007·Antimicrobial Agents and Chemotherapy·Anton Y PelegDavid L Paterson
Jul 28, 2007·Pharmacotherapy·Gail E ReidNina M Clark
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Laurence Damier-PiollePatrice Courvalin
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa L Maragakis, Trish M Perl
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Dec 6, 2008·Folia Histochemica Et Cytobiologica·Piotr WieczorekElzbieta Tryniszewska
Apr 7, 2009·The Journal of Infection·Garyphallia PoulakouHelen Giamarellou
Aug 15, 2009·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Sep 16, 2009·BMC Genomics·Clara BureauDaniel Guémené
Sep 16, 2009·Emerging Infectious Diseases·Young Kyoung ParkKwan Soo Ko
Jun 18, 2010·The Journal of Antimicrobial Chemotherapy·Michael HornseyNeil Woodford
Aug 11, 2010·Antimicrobial Agents and Chemotherapy·Sébastien CoyneBruno Périchon
Jun 28, 2011·International Journal of Antimicrobial Agents·Chao HeLanlan Wang
Jul 5, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M L MezzatestaS Stefani
Sep 16, 2011·Journal of Clinical Microbiology·Jennifer M Adams-HaduchYohei Doi
Oct 15, 2011·International Journal of Antimicrobial Agents·Han-Yueh KuoMing-Li Liou
Feb 9, 2012·Antimicrobial Agents and Chemotherapy·Meenakshi BalganeshUmender Sharma
Jul 31, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nabil KarahØrjan Samuelsen
Jan 30, 2013·Diagnostic Microbiology and Infectious Disease·Gary E Stein, Timothy Babinchak

❮ Previous
Next ❯

Citations

Nov 6, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mariana CastanheiraRonald N Jones
Jun 19, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J-R SunT-S Chiueh
Mar 6, 2016·International Journal of Antimicrobial Agents·Xi LiYunsong Yu
Sep 15, 2016·ACS Infectious Diseases·Chandradhish GhoshJayanta Haldar
Jun 10, 2015·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ming-Feng LinChung-Yu Lan
Dec 31, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sarah E CostelloMariana Castanheira
Mar 24, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Aryann R GanjoWil Goessens
May 5, 2016·BioMed Research International·Junyan QuXiaoju Lü
Jan 21, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yong ZhouMing Wang
May 18, 2016·Antimicrobial Resistance and Infection Control·Tolbert SondaFrank M Aarestrup
May 25, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ruilian LiYang Chen
Sep 14, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sara Hernando-AmadoJosé L Martínez
Nov 5, 2016·Diagnostic Microbiology and Infectious Disease·Oscar CirioniMauro Provinciali
Oct 12, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Angeliki MavroidiEvangelia D Platsouka
Apr 11, 2017·Nature Reviews. Microbiology·Terence S CroftsGautam Dantas
Apr 25, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jian LiZhihui Jiang
May 10, 2017·Nature Chemical Biology·Jooyoung ParkNiraj H Tolia
Nov 15, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Chuanling ZhangQingzhong Liu
Jul 6, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ga Eun ParkJae-Hoon Song
Jan 6, 2018·International Journal of Environmental Research and Public Health·Clemens KittingerGernot E Zarfel
Mar 20, 2015·Clinical Microbiology Reviews·Xian-Zhi LiHiroshi Nikaido
Sep 4, 2014·Antimicrobial Agents and Chemotherapy·Zi-Ke ShengMinggui Wang
Aug 14, 2019·Antimicrobial Agents and Chemotherapy·Xueyang JiaTian Qin
Aug 31, 2019·Annals of the New York Academy of Sciences·Katlego KopotsaNontombi Marylucy Mbelle
Jun 23, 2020·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Liang-Xing FangYa-Hong Liu
Mar 30, 2017·Frontiers in Cellular and Infection Microbiology·Chang-Ro LeeSang Hee Lee
Jan 22, 2019·Frontiers in Cellular and Infection Microbiology·Yu-Shan ChengWei Zheng
Dec 18, 2014·World Journal of Clinical Cases·Ming-Feng Lin, Chung-Yu Lan
Jul 26, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J-R SunT-S Chiueh

❮ Previous
Next ❯

Software Mentioned

MLST
eBURST
SPSS

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.